59
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The Importance of γ-Glutamyltransferase (GGT) Activity: A Potential Marker of Left Ventricular (LV) Diastolic Function in Diabetic Patients with Cardiovascular Disease

, , , , &
Pages 155-164 | Received 13 Oct 2009, Accepted 28 Jun 2010, Published online: 24 Sep 2010

REFERENCES

  • Skinner HA, Holt S, Schuller R, Roy J, Israel Y. Identification of alcohol abuse using laboratory tests and a history of trauma. Ann Intern Med 1984;101:847–851.
  • Jo SK, Lee WY, Rhee EJ, Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by two different criteria. Clin Chim Acta 2009;403(1–2):234–240.
  • Lim JS, Kim YJ, Chun BY, Yang JH, Lee DH, Kam S. The association between serum GGT level within normal range and risk factors of cardiovascular diseases. J Prev Med Public Health 2005;38(1):101–106.
  • Paolicchi A, Emdin M, Ghliozeni E, Atherosclerotic plaques contain gamma-glutamyl transpeptidase activity. Circulation 2004;109:1140.
  • Emdin M, Passino C, Michelassi C, Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802–1807.
  • Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112(14):2130–2137.
  • Sabanayagam C, Shankar A, Li J, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur J Epidemiol 2009;24(7):369–373.
  • Meisinger C, Löwel H, Heier M, Schneider A, Thorand B, Study Group. KORA. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005;258(6):527–535.
  • Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. J Am Med Assoc 2002;287:2570–2581.
  • Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001;24:1614–1619.
  • Cuspidi C, Meani S, Negri F, Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives?. J Hum Hypertens 2009;23(11):728–734.
  • Chen CH, Ting CT, Lin SJ, Relation between diurnal variation of blood pressure and left ventricular mass in a Chinese population. Am J Cardiol 1995;75:1239–1243.
  • Hozawa A, Okamura T, Kadowaki T, Gamma-glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis 2007;194(2):498–504.
  • Lee DH, Silventoinen K, Hu G, Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006;27(18):2170–2176.
  • Kotani K, Shimohiro H, Adachi S, Sakane N. The association between an increased level of gamma-glutamyl transferase and systolic blood pressure in diabetic subjects. Tohoku J Exp Med 2008;214(4):321–325.
  • Sen N, Basar N, Maden O, Serum gamma-glutamyl transferase activity increased in patients with coronary artery ectasia. Coron Artery Dis 2008;19(7):455–458.
  • Ulus T, Yildirir A, Sade LE, Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients?. Coron Artery Dis 2008;19(7):489–495.
  • Lavie CJ, Milani RV, Patel D, Artham SM, Ventura HO. Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function. Postgrad Med 2009;121(3):119–125.
  • Celentano A, Vaccaro O, Tammaro P, Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. Am J Cardiol 1995;76:1173–1176.
  • Demircan S, Yazici M, Durna K, The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. Clin Cardiol 2009;32(4):220–225.
  • Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078–2080.
  • Ikeda Y, Fujii J, Taniguchi N, Meister A. Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc Natl Acad Sci USA 1995;92:126–130.
  • Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A. Gammaglutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med 1997;22:853–860.
  • Camejo G, Hurt-Camejo E, Wicklund O, Bondjers G. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis 1998;139:205–222.
  • Witztum JL, Berliner JA. Oxidized phospholipids and isoprostanes in atherosclerosis. Curr Opin Lipidol 1998;9:441–448.
  • Paolicchi A, Minotti G, Tonarelli P, Gammaglutamyl transpeptidase-dependent iron reduction and LDL oxidation: a potential mechanism in atherosclerosis. J Invest Med 1999;47:151–160.
  • Lee DH, Blomhoff R, Jacobs DR Jr.. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 2004;38(6):535–539.
  • Nilssen O, Førde OH. Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study. Am J Epidemiol 1994;139(8):787–792.
  • Vozarova B, Stefan N, Lindsay RS, High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51(6):1889–1895.
  • Ikai E, Honda R, Yamada Y. Serum gamma glutamyltranspeptidase level and blood pressure in nondrinkers: a possible pathogenetic role of fatty liver in obesity-related hypertension. J Hum Hypertens 1994;8:95–100.
  • Kang YH, Min HK, Son SM, Kim IJ, Kim YK. The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Res Clin Pract 2007;77:306–313.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.